CLINICAL_TRIALS trial_result · 2022-05-03

Clinical Trial Update: The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes [Phase 2]

Phase 2 trial investigating the metabolic, metabolomic, and microbiome effects of bariatric surgery in patients with type 2 diabetes and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Mayo Clinic | Conditions: Type 2 Diabetes Mellitus, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2022-05-03